In a groundbreaking partnership aimed at revolutionizing the production processes for stem cell-based therapies, Mytos has joined forces with Aspen Neuroscience to enhance the manufacturing of autologous dopaminergic neuronal precursor cells (DANPCs). These cells are integral to Aspen’s ANPD001, an
The field of drug discovery has long been challenged by the concept of "undruggable" targets—proteins and pathways that are crucial in disease processes but difficult to target with traditional small molecule drugs. One particularly challenging target is β-catenin, a key player in the Wnt/β-catenin
The healthcare industry is witnessing an unprecedented advancement with the introduction of AI-powered wearable cameras designed to detect and prevent medication errors. These errors are a significant concern, contributing to a substantial number of preventable harms, with medication errors alone
Glioblastoma, an aggressive and often fatal form of brain cancer, has long posed a formidable challenge to medical professionals. With an average lifespan of 12 to 15 months post-diagnosis and a mere 5% survival rate five years after diagnosis, the need for innovative treatments has never been more
Penn Medicine’s Center for Cellular Immunotherapies (CCI) is at the forefront of revolutionizing cancer treatment through CAR (chimeric antigen receptor) T cell therapy. This innovative approach harnesses the power of the patient’s own immune system to target and destroy cancer cells, offering new
Randomized controlled trials (RCTs) are widely recognized as the gold standard for evaluating the efficacy of interventions. In the context of HIV research in Africa, multicenter RCTs are particularly valuable due to the diverse socio-cultural and geographical settings. This scoping review aims to
